Drug Shortage Report for ODAN-INDOMETHACIN
Report ID | 205248 |
Drug Identification Number | 02231800 |
Brand name | ODAN-INDOMETHACIN |
Common or Proper name | Indomethacin Suppositories, USP |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | INDOMETHACIN |
Strength(s) | 100MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | Boxes of 30 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-25 |
Estimated end date | 2024-09-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-11 | French | Compare |
v5 | 2024-04-11 | English | Compare |
v4 | 2024-01-22 | French | Compare |
v3 | 2024-01-22 | English | Compare |
v2 | 2023-09-26 | French | Compare |
v1 | 2023-09-26 | English | Compare |
Showing 1 to 6 of 6